FDA Clearance Tracker · P090015-S001
BOND ORACLE HER2 IHC SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 11, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Feb 11, 2014
Approved
Time to decision
200 days
Received Jul 26, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P090015-S001
- Device name
- BOND ORACLE HER2 IHC SYSTEM
- Applicant
- Leica Biosystems
- Applicant location
- Danvers, MA
- Received
- Jul 26, 2013
- Decided
- Feb 11, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P090015
Device type
- Device type
- SYSTEM, TEST, HER-2/NEU, IHC (MVC)
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE MANUFACTURING CHANGES TO THE BOND-MAX SOFTWARE, INSTRUMENT STYLING AND USABILITY, THE REAGENT AND BOND-MAX INSTRUMENT MANUFACTURING PROCESSES, AND ASSOCIATED LABELING CHANGES.
Source documents
Other decisions for Leica Biosystems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253554 · Decided Aug 7, 2026 · 266 days after receipt
Device type: Whole Slide Imaging System (PSY) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.